Luteal Phase Commencing of Growth Hormone

Completed

• Conditions: Infertility
• Interventions: Drug: Norditropin pen

• Registration Number: NCT00561769
• Lead Sponsor: Gulhane School of Medicine

Brief Summary

Commencing of growth hormone in luteal phase when follicular cohort for the next cycle is being gathered may increase mature oocytes in poor responder

Detailed Description

Not available

Study Timeline

• Study Start: 2005-01
• Status Verified: 2007-11
• Study Completion: 2007-11
• Study First Submitted: 2007-11-19
• Study First Submitted QC: 2007-11-20
• Last Update Submitted: 2007-11-20
• Study First Posted: 2007-11-21
• Last Update Posted: 2007-11-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 61

Inclusion Criteria

• Poor responder

Exclusion Criteria

• FSH >20 IU

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
A	Norditropin pen	poor responder

Primary Outcome Measures

Name	Time	Method
mature oocyte number	2 years

Secondary Outcome Measures

Name	Time	Method
pregnancy rate	2 years

Trial Locations

Locations (1)

Ren Tıp ART Center; 🇹🇷 Bursa, Turkey